FDA grants approval for first Alzheimer's drug slowing disease progression 07-Jul-2023 By Liza Laws The first and only approved anti-amyloid Alzheimer's Disease (AD) treatment shown to reduce the rate of disease progression and slow cognitive impairment has been granted approval by the FDA.
Eisai and Nichi-Iko extend partnership to target China 30-Sep-2019 By Ben Hargreaves The Japanese drugmakers will collaborate to sell generic products in China, with the aim of launching ‘one to two products’ every year.
UPDATED ACTC selects two drugs for Alzheimer’s for clinical trials 14-May-2019 By Vassia Barba Japanese pharmaceutical company Eisai sends two new Alzheimer’s prevention drugs into the clinic after ACTC selection.
